Did you know as many as 3 million Americans suffer from type 1 diabetes? It’s become quite a popular disease. In a clinical trial, an experimental drug made to block the advance of type 1 diabetes has proved strikingly effective. Tested over a period of two years, patients with relatively good control of their blood sugar levels benefited the most. However, the treatment did not benefit all patients. Some lost half or more of their ability to produce insulin. While some tweaks still need to be made, future improvements could lead to a very effective type 1 diabetes drug. For more information on the study and the drug itself, click HERE.
Category: Drugs.com
Could Tylenol Be Dangerous?
Last Thursday the Food and Drug Administration (FDA) reported that acetaminophen can cause rare, but dangerous skin reactions in some people. As one of the most widely used medicines for fever and pain relief, the FDA stated that it will require manufacturers to add warning labels to all prescriptions containing acetaminophen and will work with manufacturers of the over-the-counter drugs to do the same. The painkiller is associated with three skin diseases with symptoms ranging from rash and blisters to extensive tissue damage beneath the skin. Read the full article HERE to learn more about the potential risks and why this has not been made an issue sooner.
Plan B: The Only One of Its Kind
Not only did the Food and Drug Administration grant another three years of protection from generic competitors for the drug Plan B, but the government also permitted its spot on retail shelves. This means the pill will now be available without a prescription. After more than a decade long battle to make it more easily accessible to women who want to prevent pregnancy following unprotected sex, the government even dropped its fight to keep an age restriction on the medication after losing multiple court battles. Plan B will now be available to woman as young as 15 without a prescription. For more information on the drug and the long process it went through to reach this point, click HERE.
Vertex Pharma Being Tested as a Stock
Are investors only interested in Vertex Pharmaceuticals (VRTX) because of its cystic fibrosis drug program? We’re about to find out. After the stock exchange closed Thursday, the company announced a partial clinical hold on its first hepatitis C drug candidate by the U.S. Food and Drug Administration. Evidently, patients treated with higher doses suffered from liver toxicity. To find out more about the FDA’s reasoning and what Vertex is doing, read the full article HERE.